BSECompany Update6d ago · 3 Nov 2026, 05:33 pm
The Exchange has sought Clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.firstpost.com dated November 03, 2026 (Link : https://www.firstpost.com/business/indias-dr-reddys-gets-us-nod-for-40-generic-hiv-prevention-shot-for-120-poorer-countries-14057224.html) titled "India''s Dr Reddy''s gets US nod for $40 generic HIV prevention shot for 120 poorer countries". ....
Dr Reddys Laboratories Ltd · 500124
✦ AI Summary▲ PositiveOrder Win
Dr Reddys Laboratories Ltd has received US approval for a generic HIV prevention shot, which will be available in 120 poorer countries for $40.
Analysis Scores
Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr Reddys Laboratories Ltd - 500124 - Clarification sought from Dr Reddys Laboratories Ltd